Cargando…

Integrated Network Pharmacology and Gut Microbiota Study on the Mechanism of Huangqin Decoction in Treatment Diabetic Enteritis

OBJECTIVE: Using network pharmacology and gut microbiota sequencing to investigate the probable mechanism of Huangqin decoction in the treatment of Diabetic enteritis (DE). METHODS: The mechanism of Huangqin decoction on DE was studied by combining network pharmacology and gut microbiota sequencing...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiaomin, Fang, Cheng, Lu, Fang, Liu, Shumin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010212/
https://www.ncbi.nlm.nih.gov/pubmed/35432593
http://dx.doi.org/10.1155/2022/5080191
_version_ 1784687436152963072
author Xu, Xiaomin
Fang, Cheng
Lu, Fang
Liu, Shumin
author_facet Xu, Xiaomin
Fang, Cheng
Lu, Fang
Liu, Shumin
author_sort Xu, Xiaomin
collection PubMed
description OBJECTIVE: Using network pharmacology and gut microbiota sequencing to investigate the probable mechanism of Huangqin decoction in the treatment of Diabetic enteritis (DE). METHODS: The mechanism of Huangqin decoction on DE was studied by combining network pharmacology and gut microbiota sequencing analysis. The core components and possible targets of Huangqin decoction were analyzed by network pharmacology. The effect of Huangqin decoction on microorganisms was investigated by gut microbiota sequencing. RESULTS: The results of gut microbiota sequencing analysis showed the abundance of TM7, Tenericutes, Chloroflexi, Cyanobacteria, Acidobacteria, WS6, [Prevotella], Helicobacter, Prevotella, Lactococcus, and Anaeroplasma in the Huangqin decoction group had a significant downward. Using a network pharmacology-related database, 141 main active components of Huangqin decoction were identified, as well as 256 corresponding component targets and 1777 corresponding disease targets; the disease targets and component targets were mapped, and topological analysis was used to determine the potential of Huangqin decoction in the treatment of DE. There were 156 targets, of which the top 20 genes were selected for GO and KEGG. The KEGG results showed that 134 pathways were enriched, which was partially consistent with the metabolic pathways of gut microbiota sequencing analysis. CONCLUSION: The results show that Huangqin decoction can inhibit the expression of inflammatory factors and related inflammatory pathways in intestinal epithelial cells, thereby regulating the structure of intestinal flora. Using picurst2 for functional prediction and metabolic pathway statistics, seven metabolic pathways were obtained consistent with gut microbiota sequencing, and the NOD-like receptor signaling pathway may be its potential molecular mechanism. These results help to understand the mechanism of Huangqin decoction on DE and provide the theoretical basis for further study of Huangqin decoction.
format Online
Article
Text
id pubmed-9010212
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-90102122022-04-15 Integrated Network Pharmacology and Gut Microbiota Study on the Mechanism of Huangqin Decoction in Treatment Diabetic Enteritis Xu, Xiaomin Fang, Cheng Lu, Fang Liu, Shumin Appl Bionics Biomech Research Article OBJECTIVE: Using network pharmacology and gut microbiota sequencing to investigate the probable mechanism of Huangqin decoction in the treatment of Diabetic enteritis (DE). METHODS: The mechanism of Huangqin decoction on DE was studied by combining network pharmacology and gut microbiota sequencing analysis. The core components and possible targets of Huangqin decoction were analyzed by network pharmacology. The effect of Huangqin decoction on microorganisms was investigated by gut microbiota sequencing. RESULTS: The results of gut microbiota sequencing analysis showed the abundance of TM7, Tenericutes, Chloroflexi, Cyanobacteria, Acidobacteria, WS6, [Prevotella], Helicobacter, Prevotella, Lactococcus, and Anaeroplasma in the Huangqin decoction group had a significant downward. Using a network pharmacology-related database, 141 main active components of Huangqin decoction were identified, as well as 256 corresponding component targets and 1777 corresponding disease targets; the disease targets and component targets were mapped, and topological analysis was used to determine the potential of Huangqin decoction in the treatment of DE. There were 156 targets, of which the top 20 genes were selected for GO and KEGG. The KEGG results showed that 134 pathways were enriched, which was partially consistent with the metabolic pathways of gut microbiota sequencing analysis. CONCLUSION: The results show that Huangqin decoction can inhibit the expression of inflammatory factors and related inflammatory pathways in intestinal epithelial cells, thereby regulating the structure of intestinal flora. Using picurst2 for functional prediction and metabolic pathway statistics, seven metabolic pathways were obtained consistent with gut microbiota sequencing, and the NOD-like receptor signaling pathway may be its potential molecular mechanism. These results help to understand the mechanism of Huangqin decoction on DE and provide the theoretical basis for further study of Huangqin decoction. Hindawi 2022-04-07 /pmc/articles/PMC9010212/ /pubmed/35432593 http://dx.doi.org/10.1155/2022/5080191 Text en Copyright © 2022 Xiaomin Xu et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Xu, Xiaomin
Fang, Cheng
Lu, Fang
Liu, Shumin
Integrated Network Pharmacology and Gut Microbiota Study on the Mechanism of Huangqin Decoction in Treatment Diabetic Enteritis
title Integrated Network Pharmacology and Gut Microbiota Study on the Mechanism of Huangqin Decoction in Treatment Diabetic Enteritis
title_full Integrated Network Pharmacology and Gut Microbiota Study on the Mechanism of Huangqin Decoction in Treatment Diabetic Enteritis
title_fullStr Integrated Network Pharmacology and Gut Microbiota Study on the Mechanism of Huangqin Decoction in Treatment Diabetic Enteritis
title_full_unstemmed Integrated Network Pharmacology and Gut Microbiota Study on the Mechanism of Huangqin Decoction in Treatment Diabetic Enteritis
title_short Integrated Network Pharmacology and Gut Microbiota Study on the Mechanism of Huangqin Decoction in Treatment Diabetic Enteritis
title_sort integrated network pharmacology and gut microbiota study on the mechanism of huangqin decoction in treatment diabetic enteritis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010212/
https://www.ncbi.nlm.nih.gov/pubmed/35432593
http://dx.doi.org/10.1155/2022/5080191
work_keys_str_mv AT xuxiaomin integratednetworkpharmacologyandgutmicrobiotastudyonthemechanismofhuangqindecoctionintreatmentdiabeticenteritis
AT fangcheng integratednetworkpharmacologyandgutmicrobiotastudyonthemechanismofhuangqindecoctionintreatmentdiabeticenteritis
AT lufang integratednetworkpharmacologyandgutmicrobiotastudyonthemechanismofhuangqindecoctionintreatmentdiabeticenteritis
AT liushumin integratednetworkpharmacologyandgutmicrobiotastudyonthemechanismofhuangqindecoctionintreatmentdiabeticenteritis